SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PEGINTERFERON ALFA/RIBAVIRIN, IN CIRRHOTIC NON RESPONDERS. FIRST RESULTS OF THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)

被引：35

作者：

Hezode, C. ^{[1
]}

Dorival, C. ^{[2
]}

Zoulim, F. ^{[3
]}

Poynard, T. ^{[4
]}

Mathurin, P. ^{[5
]}

Pol, S. ^{[6
]}

Larrey, D. ^{[7
]}

Cacoub, P. ^{[4
]}

de Ledinghen, V. ^{[8
]}

Bourliere, M. ^{[9
]}

Bernard, P. H. ^{[10
]}

Riachi, G. ^{[11
]}

Alric, L. ^{[12
]}

Samuel, D. ^{[13
]}

Barthe, Y. ^{[2
]}

Fontaine, H. ^{[6
]}

Carrat, F. ^{[2
]}

Bronowicki, J. -P. ^{[14
]}

机构：

[1] Univ Paris Est, Hop Henri Mondor, INSERM, U955, Creteil, France

[2] UPMC Paris6, Hop St Antoine, INSERM, U707, Paris, France

[3] Hosp Civils Lyon, Lyon, France

[4] Hop La Pitie Salpetriere, Paris, France

[5] Hop Claude Huriez, Lille, France

[6] Univ Paris 05, Hop Cochin, INSERM, U1016, Paris, France

[7] Hop St Eloi, Montpellier, France

[8] Hop Haut Leveque, Pessac, France

[9] Fdn Hop St Joseph, Marseille, France

[10] Hop St Andre, Bordeaux, France

[11] Hop Charles Nicolle, Rouen, France

[12] Hop Purpan, Toulouse, France

[13] Hop Paul Brousse, Villejuif, France

[14] Hop Brabois, Nancy, France

来源：

关键词：

D O I：

10.1016/S0168-8278(12)60022-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S4 / S4

页数：1